Interim report Q2 2024

Bactiguard Holding AB (publ) publishes its interim report for the second quarter on Tuesday 16 July 2024 at 07:00 CET.

In connection with this, Bactiguard will host an audiocast for investors, analysts, and media at 11:00 CET. CEO Christine Lind will present the report and answer questions together with CFO Patrick Bach.

Annual and Sustainability Report 2023

Annual and Sustainability Report 2023

The Bactiguard Technology

The company’s unique technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard’s infection prevention solutions decrease patient suffering, save lives, and unburden healthcare resources while also fighting against antimicrobial resistance, one of the most serious threats to global health and modern medicine.


To champion a healthier world by preventing infections.


To be the global standard of care for preventing medical device related infections.


To be the premier partner for leading MedTech companies, joining forces to redefine healthcare and improve health worldwide.

Core values

  • Respect
  • Trust
  • Transparency
  • Performance

Bactiguard is a purpose-driven company with a strong corporate culture, firmly anchored in four core values. The values are an integral part of Bactiguard’s purpose to champion a healthier world by preventing infections and a prerequisite to achieve our targets.

Bactiguard as an investment

The ambition is to become a profitable knowledge and specialist organization which is a prerequisite to deliver on our financial, strategic and sustainability targets.

  • 16
    Jul 2024

    Interim report Q2 April 1 – June 30 2024

  • 19
    Sep 2024

    Bactiguard presents at Pareto Securities Annual Healthcare Conference in Stockholm

  • 24
    Oct 2024

    Interim report Q3 July 1 – September 30 2024

Media & Investor Relations

  • Nina Nornholm

    Nina Nornholm

    Head of Corporate Communication & Investor Relations

    +46 70 855 0356